Fast Worldwide Shipping With Tracked 48 hour DHL Express Delivery
CJC-1295+DAC 5mg(GHRH)
(Triacontapeptide–30 Amino Acids)
( Product no. 871-38 )
£36.99
DAC‑Enhanced GHRH Analogue for Extended Studies
CJC-1295 with DAC supplied exclusively for in-vitro laboratory research. This long acting growth hormone releasing hormone (GHRH) analogue is widely referenced in scientific literature examining sustained endocrine signalling models, IGF-1 pathway interaction, and peptide receptor binding behaviour under controlled laboratory conditions. Supplied in a stable lyophilised format, CJC-1295 with DAC supports precise handling, reproducibility, and consistency.
CJC-1295+DAC 5mg
(GHRH)
Premium Grade | UK Supply
Product Overview
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic peptide analogue of growth hormone–releasing hormone (GHRH), developed to provide prolonged stimulation of endogenous growth hormone secretion. Through the incorporation of a Drug Affinity Complex, CJC-1295 is engineered to reversibly bind to circulating plasma proteins, significantly extending its functional activity compared to native GHRH and shorter-acting analogues. Within research environments, CJC-1295 with DAC is utilised to examine sustained growth hormone signalling, endocrine rhythm modulation, and long-term activation of the GH–IGF-1 axis. Its extended activity profile allows researchers to study continuous hormonal stimulation while maintaining physiological regulation mechanisms, making it a valuable compound for investigations requiring stable and prolonged endocrine engagement. Due to its molecular stability, receptor specificity, and predictable pharmacokinetic profile, CJC-1295 with DAC is widely recognised in peptide research as a specialised tool for exploring growth hormone–mediated metabolic, anabolic, and regulatory processes.
(Recommend, Reconstitute with-Acetic Acid)
Scientific Background
CJC-1295 is structurally based on growth hormone–releasing hormone, with targeted amino acid substitutions that enhance resistance to enzymatic degradation. The addition of the Drug Affinity Complex enables covalent but reversible binding to serum albumin, dramatically extending the peptide’s half-life and allowing sustained interaction with GHRH receptors located on somatotroph cells of the anterior pituitary. Upon receptor activation, CJC-1295 with DAC initiates intracellular signalling pathways involving cyclic AMP (cAMP) and protein kinase A, leading to increased synthesis and pulsatile release of growth hormone. This prolonged stimulation results in elevated and sustained downstream production of insulin-like growth factor-1 (IGF-1), a key mediator of cellular growth, metabolic regulation, and tissue maintenance. Importantly, despite its extended activity, CJC-1295 with DAC preserves endogenous feedback mechanisms. Regulatory control via somatostatin and IGF-1 remains intact, allowing for detailed study of long-term endocrine adaptation, receptor sensitivity, and hormonal homeostasis without forced hormone replacement.
Research Applications
CJC-1295 with DAC is extensively researched in endocrinology and metabolic science, particularly in studies examining prolonged growth hormone exposure and its systemic effects. Researchers utilise this peptide to investigate sustained GH–IGF-1 signalling, endocrine rhythm stability, and the physiological impact of extended hormone release patterns. In metabolic research, CJC-1295 with DAC is explored for its role in lipid metabolism regulation, energy utilisation pathways, and nutrient partitioning, all of which are closely linked to growth hormone activity. Its long-acting profile makes it especially suitable for experimental models requiring consistent hormonal signalling over extended periods. Additionally, CJC-1295 with DAC is used in studies focused on cellular regeneration, protein synthesis, and tissue maintenance processes associated with growth hormone signalling. Its unique pharmacological design allows researchers to assess chronic endocrine stimulation, adaptive hormonal responses, and long-term GH receptor dynamics in controlled laboratory settings.
(Read More About CJC-1295+DAC In Our Article)
Technical Specifications
- Contents: 5mg CJC-1295 + DAC
- Form: Lyophilized powder
- Purity: >99% (HPLC Verified)
- Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
- Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-
Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-
Ile-Leu-Ser-Arg-Lys-DAC - Peptide Length: 30 Amino-Acids
- pH Range: 4.5-7.0
- Storage: Store between 2°C and 8°C
Note: Reconstitute with 50% Bacteriostatic (BAC) water and 50% Acetic Acid for best results.
Related Research Compounds
Hexarelin 5mg
IGF-1 LR3 1mg
GHRP-6 10mg
Internal Research Sources
Trade supply
Peptides sets
Bulk purchase range
Disclaimer
CJC-1295 with DAC supplied exclusively for in-vitro laboratory research. This long acting growth hormone releasing hormone (GHRH) analogue is widely referenced in scientific literature examining sustained endocrine signalling models, IGF-1 pathway interaction, and peptide receptor binding behaviour under controlled laboratory conditions. Supplied in a stable lyophilised format, CJC-1295 with DAC supports precise handling, reproducibility, and consistency.
CJC-1295+DAC 5mg
(GHRH)
Premium Grade | UK Supply
Product Overview
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic peptide analogue of growth hormone–releasing hormone (GHRH), developed to provide prolonged stimulation of endogenous growth hormone secretion. Through the incorporation of a Drug Affinity Complex, CJC-1295 is engineered to reversibly bind to circulating plasma proteins, significantly extending its functional activity compared to native GHRH and shorter-acting analogues. Within research environments, CJC-1295 with DAC is utilised to examine sustained growth hormone signalling, endocrine rhythm modulation, and long-term activation of the GH–IGF-1 axis. Its extended activity profile allows researchers to study continuous hormonal stimulation while maintaining physiological regulation mechanisms, making it a valuable compound for investigations requiring stable and prolonged endocrine engagement. Due to its molecular stability, receptor specificity, and predictable pharmacokinetic profile, CJC-1295 with DAC is widely recognised in peptide research as a specialised tool for exploring growth hormone–mediated metabolic, anabolic, and regulatory processes.
(Recommend, Reconstitute with-Acetic Acid)
Scientific Background
CJC-1295 is structurally based on growth hormone–releasing hormone, with targeted amino acid substitutions that enhance resistance to enzymatic degradation. The addition of the Drug Affinity Complex enables covalent but reversible binding to serum albumin, dramatically extending the peptide’s half-life and allowing sustained interaction with GHRH receptors located on somatotroph cells of the anterior pituitary. Upon receptor activation, CJC-1295 with DAC initiates intracellular signalling pathways involving cyclic AMP (cAMP) and protein kinase A, leading to increased synthesis and pulsatile release of growth hormone. This prolonged stimulation results in elevated and sustained downstream production of insulin-like growth factor-1 (IGF-1), a key mediator of cellular growth, metabolic regulation, and tissue maintenance. Importantly, despite its extended activity, CJC-1295 with DAC preserves endogenous feedback mechanisms. Regulatory control via somatostatin and IGF-1 remains intact, allowing for detailed study of long-term endocrine adaptation, receptor sensitivity, and hormonal homeostasis without forced hormone replacement.
Research Applications
CJC-1295 with DAC is extensively researched in endocrinology and metabolic science, particularly in studies examining prolonged growth hormone exposure and its systemic effects. Researchers utilise this peptide to investigate sustained GH–IGF-1 signalling, endocrine rhythm stability, and the physiological impact of extended hormone release patterns. In metabolic research, CJC-1295 with DAC is explored for its role in lipid metabolism regulation, energy utilisation pathways, and nutrient partitioning, all of which are closely linked to growth hormone activity. Its long-acting profile makes it especially suitable for experimental models requiring consistent hormonal signalling over extended periods. Additionally, CJC-1295 with DAC is used in studies focused on cellular regeneration, protein synthesis, and tissue maintenance processes associated with growth hormone signalling. Its unique pharmacological design allows researchers to assess chronic endocrine stimulation, adaptive hormonal responses, and long-term GH receptor dynamics in controlled laboratory settings.
(Read More About CJC-1295+DAC In Our Article)
Technical Specifications
- Contents: 5mg CJC-1295 + DAC
- Form: Lyophilized powder
- Purity: >99% (HPLC Verified)
- Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
- Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-
Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-
Ile-Leu-Ser-Arg-Lys-DAC - Peptide Length: 30 Amino-Acids
- pH Range: 4.5-7.0
- Storage: Store between 2°C and 8°C
Note: Reconstitute with 50% Bacteriostatic (BAC) water and 50% Acetic Acid for best results.
Related Research Compounds
Hexarelin 5mg
IGF-1 LR3 1mg
GHRP-6 10mg
Internal Research Sources
Trade supply
Peptides sets
Bulk purchase range
Disclaimer
You may also like
How to Reconstitute Your Peptides
What You Will Need
- Lyophilized peptide vial
- Sterile solvent (such as bacteriostatic water or another suitable choice)
- 1 ml sterile syringe with a fine (29–30g) needle
- Sterile alcohol wipes
- Calculator for dilution and dosage accuracy
- Labels for marking each aliquot with concentration and date
- Sterile workspace or biosafety cabinet (recommended for best practice)
Preparation Steps
Allow the vial to reach room temperature
This helps prevent condensation, which can compromise sterility when you open the vial.
Draw up the solvent
Using a sterile syringe, measure the precise amount of bacteriostatic water or your chosen solvent.
Inject the solvent gently
Insert the needle into the vial at a 45-degree angle so the liquid runs down the inside wall, which reduces bubbling and foam.
Dissolve the peptide
Swirl the vial gently until the peptide powder is completely dissolved. Avoid shaking, as this can damage the peptide bonds.
Aliquot the solution
If smaller, single-use portions are needed, divide the solution into sterile microtubes using a new, sterile syringe or pipette for each.
Ask a Question
If you have any questions regarding our research peptides for sale, please feel free to reach out below.
Quick Links
Policies
Tips for Storing Your Peptides
General Storage Guidelines
- Store all peptides in airtight, moisture-resistant containers to prevent exposure to humidity.
- Minimise freeze-thaw cycles by dividing peptides into single-use aliquots whenever possible.
- Protect peptides from light, especially if they are modified or known to be photosensitive, by storing them in amber vials or wrapping them in foil.
- Always practice sterile handling and accurate labelling, including peptide name, concentration, date, and storage conditions.
Lyophilised Peptides
- Keep lyophilised (freeze-dried) peptides at minus 20°C or lower for long-term stability.
- Ensure the container is sealed tightly to keep out moisture.
- Allow the vial to reach room temperature before opening to avoid condensation, which can degrade the peptide.
- Only open vials in a dry environment to prevent humidity from affecting the product.
Reconstituted Peptides
- Store peptides reconstituted with sterile water or buffer at 2°C to 8°C and use within 1–12 weeks.
- If peptides are dissolved in DMSO or other organic solvents, store them at minus 20°C and protect from light.
- Always aliquot into single-use volumes immediately after reconstitution to avoid repeated freeze-thaw cycles.
- Clearly label all aliquots with relevant information and only thaw as needed to preserve the peptide’s activity and integrity.
Read More on Storage Guidelines
Ask a Question
If you have any questions regarding our research peptides for sale, please feel free to reach out below.
Quick Links
Policies
Shipping and Postage
UK & European Delivery
Evri UK Tracked 1-2 Business Days
This costs; £4.99 per order
European DHL Express Tracked 1-2 Days
This cost; £24.99 per order
Bioplex Peptides offers fast and reliable 1-2 days delivery across the UK with full tracking included. Note; Due to the nature of our products, we only dispatch samples between Monday-Thursday, orders after 12pm will be shipped the following day.
*We aim to dispatch and deliver orders within the stated timeframes, but delays can occur due to severe weather, transport issues, public holidays, or other unforeseen events. Once an order has been dispatched, extended delivery times are outside our control.
International Delivery
United States of America & Canada 1-2 Business Days
This cost; £24.99 per order
International Delivery 1-3 Business Days
This cost; £29.99 per order
Bioplex Peptides offers fast and reliable 1-3 days worldwide delivery with full tracking included using the worlds fastest and most reliable courier available with a discounted rate for all EU & International customers. Delays may occur due to natural causes such as severe weather conditions, transportation disruptions, public holidays, or other unforeseen events. All international samples ship Monday–Saturday, ensuring steady worldwide delivery scheduling.
Order Processing
Orders are typically processed within 24hrs after payment confirmation. Custom peptide synthesis orders and wholesale orders may require additional lead time depending on complexity and quantity. Clients will be notified of estimated delivery timelines upon order confirmation.
Shipping Methods and Carriers
We utilize reliable courier services such DHL Express Premium 1-2 Business days for all International deliveries and Evri & Royal Mail tracked 1-2 days delivery for all United Kingdom deliveries to ensure timely and traceable delivery. Shipping options may vary depending on destination, order size, and regulatory requirements.
BioPleX Peptides is not responsible for delays caused by customs clearance, weather disruptions, or carrier-related issues.
Returns and Refunds
Due to the specialised and perishable nature of our research peptide products, BioPlex Peptides does not offer general refunds or accept returns once an order has been shipped. All purchases are considered final unless they meet specific criteria outlined below.
Refunds and Replacements
We do not provide refunds for products that have been correctly fulfilled and delivered. However, if an item arrives damaged, compromised, or incorrect due to an error on our part, we will offer a replacement at no additional cost. Claims must be submitted within 48 hours of delivery, accompanied by photographic evidence and a description of the issue.
Missing Parcels
If your parcel has not arrived within the estimated delivery window, please contact our logistics team promptly. We will initiate an investigation with the carrier and provide updates throughout the process. If the parcel is confirmed lost, we will issue a replacement shipment or credit, depending on the circumstances.
Order Cancellation
Orders may be cancelled within 24 hours of placement, provided production has not yet begun. Custom peptide synthesis orders are non-cancellable once processing has started. To request a cancellation, please email us at enquiries@bioplexpeptides.co.uk with your order number and reason for cancellation.
Damaged or Incorrect Items
In the rare event that you receive a damaged or incorrect item, please notify us within 48 hours of receipt. Include your order number, photos of the product and packaging, and a description of the issue. We will assess the claim and, if validated, arrange for a replacement to be shipped promptly.
Read More on Our Returns & Refunds Policy
Ask a Question
If you have any questions regarding our research peptides for sale, please feel free to reach out below.
Quick Links
Policies
